AN2 Therapeutics: Funding, Investors & Team (Sep 2026)
AN2 Therapeutics, Inc. is a biopharmaceutical company that operates globally and is situated in California. It specializes in using advanced biomedical and drug development knowledge to create innovative medications for individuals afflicted with infectious diseases. Established in 2017, the company is headquartered in Menlo Park, California, United States.
AN2 Therapeutics has raised $110M across 3 funding rounds on record, the most recent an undisclosed round of $40.0M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AN2 Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
AN2 Therapeutics Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
AN2 Therapeutics raised $70.0M in an undisclosed round announced in Aug 2023.
1.2 years later, an undisclosed round was announced in Oct 2024 with no disclosed amount.
1.4 years later, an undisclosed round of $40.0M was announced in Mar 2026.
AN2 Therapeutics Founders and Leadership Team
Contact details for the AN2 Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →AN2 Therapeutics Funding Compared to Other Biotechnology Startups
AN2 Therapeutics' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AN2 Therapeutics in Biotechnology and Menlo Park
Companies Similar to AN2 Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
AN2 Therapeutics Funding FAQs
What does AN2 Therapeutics do?
AN2 Therapeutics, Inc. is a biopharmaceutical company that operates globally and is situated in California. It specializes in using advanced biomedical and drug development knowledge to create innovative medications for individuals afflicted with infectious diseases. Established in 2017, the company is headquartered in Menlo Park, California, United States.
How much funding has AN2 Therapeutics raised?
AN2 Therapeutics has raised $110M across 3 rounds on record. The most recent is an undisclosed round of $40.0M announced in Mar 2026.
When did AN2 Therapeutics last raise funding?
AN2 Therapeutics' most recent funding round on record is an undisclosed round of $40.0M, announced in Mar 2026.
Who founded AN2 Therapeutics?
FundedIQ lists Eric Easom (Founder) at AN2 Therapeutics.
Where is AN2 Therapeutics headquartered?
AN2 Therapeutics is based in Menlo Park, California, United States.
How many employees does AN2 Therapeutics have?
AN2 Therapeutics is in the 11-50 employee band.
How does AN2 Therapeutics' funding compare to other Biotechnology startups?
AN2 Therapeutics' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's AN2 Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AN2 Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.